Thursday, October 03, 2019 2:19:54 PM
Phyton BioTech resubmitted, Sept. 30th, 2019, an updated Oral Hearing Patent request for Synthesizing "PRODUCTION OF THAPSIGARGINS BY THAPSIA CELL SUSPENSION CULTURE".
Once they get this patent approved they will solve the Commercial Supply issues. Its been ongoing Since 2016.... Coincidentally around the same time $NSPX started getting quite.
https://portal.uspto.gov/pair/PublicPair -
Application Number - 15/100780
Think about it...
Started getting current in April 2019
June 17th, 2019 Updated Phase II report Published, no hype/PR.. Just Published Medically and Scientifically. https://www.mdpi.com/2072-6694/11/6/833
September 13th, 2019 They become fully reported..
October 1st, 2019 minimal RS..
October 3, 2019 Commercial Supply issue on verge of being resolved with the excepted review of the Patent submission.
During this entire time the only money the company has spent was on Getting SEC updated and OTC Current.
There are no fake/misleading/hype/crappy PR's promising anything.
$NSPX STRONGER
Recent RBSH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:19:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:36:33 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM